Matteo Bologna

Prof. Matteo Bologna

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in Brain
Verified
Journal Article
Open access
PDF file
Matteo BolognaMatteo Bologna
Matteo Bologna
GPGiulia Paparella
Giulia Paparella
AFAlfonso Fasano
Alfonso Fasano
MHMark Hallett
Mark Hallett
ABAlfredo Berardelli
Alfredo Berardelli
Bradykinesia is one of the cardinal motor symptoms of Parkinson’s disease and other parkinsonisms. The various clinical aspects related to bradykinesia and the pathophysiological mechanisms underlying bradykinesia are, however, still unclear. In this article, we review clinical and experimental studies on bradykinesia performed in patients with Parkinson’s disease and atypical parkinsonism. We also review studies on animal experiments dealing with pathophysiological aspects of the parkinsonian state. In Parkinson’s disease, bradykinesia is characterized by slowness, the reduced amplitude of movement, and sequence effect. These features are also present in atypical parkinsonisms, but the sequence effect is not common. Levodopa therapy improves bradykinesia, but treatment variably affects the bradykinesia features and does not significantly modify the sequence effect. Findings from animal and patients demonstrate the role of the basal ganglia and other interconnected structures, such as the primary motor cortex and cerebellum, as well as the contribution of abnormal sensorimotor processing. Bradykinesia should be interpreted as arising from network dysfunction. A better understanding of bradykinesia pathophysiology will serve as the new starting point for clinical and experimental purposes.

12 December 2012 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
Matteo BolognaMatteo Bologna
Matteo Bologna
GFGiovanni Fabbrini
Giovanni Fabbrini
Luca MarsiliLuca Marsili
Luca Marsili
GDGiovanni Defazio
Giovanni Defazio
PTP. D. Thompson
P. D. Thompson
ABAlfredo Berardelli
Alfredo Berardelli
The aim of this paper is to summarise the main clinical and pathophysiological features of facial bradykinesia in Parkinson's disease (PD) and in atypical parkinsonism. Clinical observation suggests that reduced spontaneous and emotional facial expressions are features of facial bradykinesia in PD and atypical parkinsonism. In atypical parkinsonism, facial bradykinesia is complicated by additional dystonic features. Experimental studies evaluating spontaneous and emotional facial movements demonstrate that PD is characterised by a reduction in spontaneous blinking and emotional facial expression. In PD, neurophysiological studies show that voluntary orofacial movements are smaller in amplitude and slower in velocity. In contrast, movements of the upper face (eg, voluntary blinking) are normal in terms of velocity and amplitude but impaired in terms of switching between the closing and opening phases. In progressive supranuclear palsy (PSP), voluntary blinking is not only characterised by a severely impaired switching between the closing and opening phases of voluntary blinking, but is also slow in comparison with PD. In conclusion, in PD, facial bradykinesia reflects abnormalities of spontaneous, emotional and voluntary facial movements. In PSP, spontaneous and voluntary facial movements are abnormal but experimental studies on emotional facial movements are lacking. Data on facial bradykinesia in other atypical parkinsonism diseases, including multiple system atrophy and corticobasal degeneration, are limited. In PD, facial bradykinesia is primarily mediated by basal ganglia dysfunction whereas in PSP, facial bradykinesia is a consequence of a widespread degeneration involving the basal ganglia, cortical and brainstem structures.

12 June 2018 in Brain
Verified
Journal Article
Closed access
PDF file
Matteo BolognaMatteo Bologna
Matteo Bologna
AGAndrea Guerra
Andrea Guerra
giulia paparellagiulia paparella
giulia paparella
LGLaura Giordo
Laura Giordo
DFDanilo Alunni Fegatelli
Danilo Alunni Fegatelli
ABAlfredo Berardelli
Alfredo Berardelli
Many neurophysiological abnormalities have been described in the primary motor cortex of patients with Parkinson’s disease. However, it is unclear whether there is any relationship between them and bradykinesia, one of the cardinal motor features of the condition. In the present study we aimed to investigate whether objective measures of bradykinesia in Parkinson’s disease have any relationship with neurophysiological measures in primary motor cortex as assessed by means of transcranial magnetic stimulation techniques. Twenty-two patients with Parkinson’s disease and 18 healthy subjects were enrolled. Objective measurements of repetitive finger tapping (amplitude, speed and decrement) were obtained using a motion analysis system. The excitability of primary motor cortex was assessed by recording the input/output curve of the motor-evoked potentials and using a conditioning-test paradigm for the assessment of short-interval intracortical inhibition and facilitation. Plasticity-like mechanisms in primary motor cortex were indexed according to the amplitude changes in motor-evoked potentials after the paired associative stimulation protocol. Patients were assessed in two sessions, i.e. OFF and ON medication. A canonical correlation analysis was used to test for relationships between the kinematic and neurophysiological variables. Patients with Parkinson’s disease tapped more slowly and with smaller amplitude than normal, and displayed decrement as tapping progressed. They also had steeper input/output curves, reduced short-interval intracortical inhibition and a reduced response to the paired associative stimulation protocol. Within the patient group, bradykinesia features correlated with the slope of the input/output curve and the after-effects of the paired associative stimulation protocol. Although dopaminergic therapy improved movement kinematics as well as neurophysiological measures, there was no relationship between them. In conclusion, neurophysiological changes in primary motor cortex relate to bradykinesia in patients with Parkinson’s disease, although other mechanisms sensitive to dopamine levels must also play a role.

3 January 2008 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
RARocco Agostino
Rocco Agostino
Matteo BolognaMatteo Bologna
Matteo Bologna
LDLoredana Dinapoli
Loredana Dinapoli
BGBruno Gregori
Bruno Gregori
GFGiovanni Fabbrini
Giovanni Fabbrini
ABAlfredo Berardelli
Alfredo Berardelli

1 May 2012 in Neurology
Verified
Journal Article
Closed access
PDF file
MKM. Kojovic
M. Kojovic
Matteo BolognaMatteo Bologna
Matteo Bologna
PKP. Kassavetis
P. Kassavetis
NMN. Murase
N. Murase
FPF.J. Palomar
F.J. Palomar
KBK.P. Bhatia
K.P. Bhatia
Objective: Compensatory reorganization of the nigrostriatal system is thought to delay the onset of symptoms in early Parkinson disease (PD). Here we sought evidence that compensation may be a part of a more widespread functional reorganization in sensorimotor networks, including primary motor cortex. Methods: Several neurophysiologic measures known to be abnormal in the motor cortex (M1) of patients with advanced PD were tested on the more and less affected side of 16 newly diagnosed and drug-naive patients with PD and compared with 16 age-matched healthy participants. LTP-like effects were probed using a paired associative stimulation protocol. We also measured short interval intracortical inhibition, intracortical facilitation, cortical silent period, and input/output curves. Results: The less affected side in patients with PD had preserved intracortical inhibition and a larger response to the plasticity protocol compared to healthy participants. On the more affected side, there was no response to the plasticity protocol and inhibition was reduced. There was no difference in input/output curves between sides or between patients with PD and healthy participants. Conclusions: Increased motor cortical plasticity on the less affected side is consistent with a functional reorganization of sensorimotor cortex and may represent a compensatory change that contributes to delaying onset of clinical symptoms. Alternatively, it may reflect a maladaptive plasticity that provokes symptom onset. Plasticity deteriorates as the symptoms progress, as seen on the more affected side. The rate of change in paired associative stimulation response over time could be developed into a surrogate marker of disease progression in PD.

1 March 2006 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
CCCarlo Colosimo
Carlo Colosimo
Matteo BolognaMatteo Bologna
Matteo Bologna
SLSimona Lamberti
Simona Lamberti
LALucio Avanzino
Lucio Avanzino
Lucio MarinelliLucio Marinelli
Lucio Marinelli
ABAlfredo Berardelli
Alfredo Berardelli
Hemifacial spasm (HFS) is a peripherally induced movement disorder characterized by involuntary and unilateral contractions involving the upper and lower facial muscles.1-3 Hemifacial spasm is a long-term disease from which patients rarely recover spontaneously. Primary HFS is commonly attributed to vascular loops compressing the seventh cranial nerve at its exit zone from the brainstem. The facial nerve compression is thought to lead to ephaptic transmission and to hyperactivity of the facial nucleus, resulting in the involuntary facial movements.4,5 Secondary HFS frequently follows peripheral facial palsy or may arise from facial nerve damage produced by tumors, demyelinating disorders, traumatisms, and infections.3